Related Experiment Video
Updated: May 22, 2026

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah
Published on: June 24, 2025
Perinatal cytomegalovirus hepatitis in Saudi infants: a case series
Mohammed Y Hasosah1, Suzane Y Kutbi, Abdulfattah W Al-Amri
1Department of Pediatric Gastroenterology, King Saud Bin Abdulaziz University for Health Sciences/National Guard Health Affairs, Western Region, Jeddah, Saudi Arabia. hasosah2007@yahoo.com
Background/Aim:
Cytomegalovirus (CMV) is the most common congenital viral infection, occurring in 0.4%-2.3% of all live births. The clinical manifestations of CMV are multiorgan involvement. Currently, the numbers of studies of hepatic CMV infection in immunocompetent infants are insufficient and little information exists in the medical literature about the hepatic manifestations and complications of CMV.
Patients And Methods:
Nine infants diagnosed with hepatic CMV infection were included in the study. The diagnosis was based on the presence of IgM anti-CMV antibodies titer in serum and detection of CMV-DNA in blood. The authors identified clinical characteristics, biochemical characteristics, immunologic markers, and the outcome of hepatic CMV with or without treatment.
Results:
Jaundice was the most common clinical feature of CMV infection in infancy (100%). Hepatic abnormalities in the form of cholestasis (defined as a serum conjugated bilirubin concentration greater than 17.1 μmol/L or greater than 20% of the total serum bilirubin) were found in all patients (100%), hepatitis (77%), hypoalbuminemia (55%), elevated alkaline phosphatase, and gamma-glutamyltransferase (77%). Other findings showed hepatosplenomegaly (44%), thrombocytopenia (22%) and low birth weight (11%) The treatment of hepatic CMV infection was indicated in 66% and was not indicated in 33%. Both of them had resolved cholestasis and hepatitis.
Conclusion:
Jaundice and cholestasis were the most common clinical features of hepatic CMV infections. Hepatic CMV infection in young infants is often a self-limited illness that does not require antiviral therapy. Most of the patients with hepatic CMV infection had a favorable outcome.
Insights
Cytomegalovirus (CMV) infection in infants commonly causes jaundice and cholestasis. Most cases of hepatic CMV infection in infants are self-limiting and resolve favorably, often without needing antiviral treatment.
Area of Science:
- Pediatrics
- Infectious Diseases
- Hepatology
Background:
- Cytomegalovirus (CMV) is the most frequent congenital viral infection, affecting 0.4%-2.3% of newborns.
- CMV infection can manifest in multiple organs, but studies on hepatic CMV in immunocompetent infants are limited.
- There is a scarcity of medical literature detailing the hepatic manifestations and complications of CMV in this population.
Purpose of the Study:
- To investigate the clinical characteristics, biochemical features, and outcomes of hepatic Cytomegalovirus (CMV) infection in infants.
- To assess the necessity and efficacy of antiviral therapy for hepatic CMV in immunocompetent infants.
Main Methods:
- The study included nine infants diagnosed with hepatic CMV infection.
- Diagnosis was confirmed by positive IgM anti-CMV antibodies and CMV-DNA detection in blood.
- Clinical, biochemical, and immunological data were analyzed, along with treatment outcomes.
Main Results:
- Jaundice (100%) and cholestasis (100%) were the predominant clinical features.
- Hepatic abnormalities included hepatitis (77%), hypoalbuminemia (55%), and elevated liver enzymes (77%).
- Hepatosplenomegaly (44%) and thrombocytopenia (22%) were also observed; treatment was indicated in 66% of cases, with favorable resolution in all.
Conclusions:
- Jaundice and cholestasis are the most common signs of hepatic CMV infection in infants.
- Hepatic CMV infection in young infants is frequently self-limiting and may not require antiviral therapy.
- The majority of infants with hepatic CMV infection experience a favorable outcome.
Related Concept Videos
Cytomegalovirus Disease
Viral Hepatitis I: Introduction
Viral Meningitis
Hepatitis
Bacterial Gastroenteritis
Bacterial Meningitis I: Introduction
